Track Becton, Dickinson and Company — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Becton, Dickinson and Company BDX · Stock Open Becton, Dickinson and Company in new tab

180.85 USD
Add to portfolio
P/E
30.77
EPS
5.78
Yield
2.20%
Safety Score
56
P/B
1.98
ROE
6.61
Beta
0.28
Target Price
195.67 USD
Becton, Dickinson and Company logo

Becton, Dickinson and Company

🧾 Earnings Recap – Q3 2026

BD's shares rose 3.6% post-earnings, driven by revenue growth above expectations and an upward revision to adjusted EPS guidance, signaling market approval of the company’s focused portfolio and operational execution.

  • Revenue reached $5 billion, up 4.4% year-over-year on an FX-neutral basis, with over 90% of the portfolio delivering high single-digit growth.
  • Adjusted operating margin expanded to 24.9%, reflecting improved mix and operational efficiency under the BD Excellence program.
  • Adjusted EPS came in at $3.23, prompting a raised midpoint for full-year EPS guidance and updated revenue growth target toward the high end of low single digits.
  • Broad-based growth was supported by double-digit expansion in biologic drug delivery, advanced patient monitoring, PureWick, and advanced tissue regeneration platforms.
  • Commercial investments in key segments like Advanced Patient Monitoring and PureWick contributed to accelerating growth and share gains, particularly in the U.S. market.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateNov. 5, 2026
P/E30.77
EPS5.78
Book Value89.64
Price to Book1.98
Debt/Equity68.84
% Insiders0.435%
Growth
Revenue Growth0.05%
Earnings Growth-0.31%
Estimates
Forward P/E13.38
Forward EPS13.29
Target Mean Price195.67
Dividend
Dividend Yield2.20%
Annual dividends3.98 USD
Ex-Div. DateSept. 9, 2026
Payout187.14%
5y avg Yield1.45%

DCF Valuation

Tweak assumptions to recompute fair value for Becton, Dickinson and Company (BDX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Becton, Dickinson and Company Logo Becton, Dickinson and Company Analysis (BDX)

United States Health Care Official Website Stock

Is Becton, Dickinson and Company a good investment? Becton, Dickinson and Company (BDX) is currently trading at 180.85 USD. Market analysts have a consensus price target of 195.67 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 30.77. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Becton, Dickinson and Company is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is 13.29.

For income investors, Becton, Dickinson and Company pays a dividend yield of 2.20%. With a payout ratio of 187%, the dividend appears to be under pressure.

Investor FAQ

Does Becton, Dickinson and Company pay a dividend?

Yes, it pays an annual dividend of 3.98 USD (2.20% yield).

What asset class is Becton, Dickinson and Company?

Becton, Dickinson and Company is classified as a Stock. You can compare it against 6 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 5.78.

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Exchange Ticker
CNQ (Canada) BDX.CN
BOX.SG
NYQ (United States) BDX
LSE (United Kingdom) 0R19.L
SES (Singapore) BDX.SI
FRA (Germany) BOX.F
Trades
Dividend Yield
2.20%
5y avg 1.45%
Annual Dividends
3.98USD
Next Ex. Div Date
Sept. 9, 2026
Payout Ratio
187.14%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
2.21 USD
June 30, 2027 (estimated) 1.1064
March 31, 2027 (estimated) 1.1064
▸2026
4.03 USD
Dec. 31, 2026 (estimated) 0.8789
Sept. 30, 2026 1.0500
June 30, 2026 1.0500
March 31, 2026 1.0500
▸2025
3.28 USD
Dec. 31, 2025 0.8255
Sept. 30, 2025 0.8176
June 30, 2025 0.8176
March 31, 2025 0.8176
▸2024
3.06 USD
Dec. 31, 2024 0.8176
Sept. 30, 2024 0.7469
June 28, 2024 0.7469
March 29, 2024 0.7469
▸2023
2.89 USD
Dec. 29, 2023 0.7469
Sept. 29, 2023 0.7154
June 30, 2023 0.7154
March 31, 2023 0.7154
▸2022
2.75 USD
Dec. 30, 2022 0.7154
Sept. 30, 2022 0.6840
June 30, 2022 0.6840
March 31, 2022 0.6673
▸2021
2.58 USD
Dec. 31, 2021 0.6673
Sept. 30, 2021 0.6366
June 30, 2021 0.6366
March 31, 2021 0.6366
▸2020
2.45 USD
Dec. 31, 2020 0.6366
Sept. 30, 2020 0.6059
June 30, 2020 0.6059
March 31, 2020 0.6059
▸2019
2.38 USD
Dec. 31, 2019 0.6059
Sept. 30, 2019 0.5906
June 28, 2019 0.5906
March 29, 2019 0.5906
▸2018
2.32 USD
Dec. 31, 2018 0.5906
Sept. 28, 2018 0.5752
June 29, 2018 0.5752
March 30, 2018 0.5752
▸2017
2.25 USD
Dec. 29, 2017 0.5752
Sept. 29, 2017 0.5599
June 30, 2017 0.5599
March 31, 2017 0.5599
▸2016
2.08 USD
Dec. 30, 2016 0.5599
Sept. 30, 2016 0.5062
June 30, 2016 0.5062
March 31, 2016 0.5062
▸2015
1.89 USD
Dec. 31, 2015 0.5062
Sept. 30, 2015 0.4602
June 30, 2015 0.4602
March 31, 2015 0.4602
▸2014
1.71 USD
Dec. 31, 2014 0.4602
Sept. 30, 2014 0.4180
June 30, 2014 0.4180
March 31, 2014 0.4180
▸2013
1.56 USD
Dec. 31, 2013 0.4180
Sept. 30, 2013 0.3797
June 28, 2013 0.3797
March 29, 2013 0.3797
▸2012
1.42 USD
Dec. 31, 2012 0.3797
Sept. 28, 2012 0.3451
June 29, 2012 0.3451
March 30, 2012 0.3451
▸2011
1.29 USD
Dec. 30, 2011 0.3451
Sept. 30, 2011 0.3145
June 30, 2011 0.3145
March 31, 2011 0.3145
▸2010
1.45 USD
Dec. 31, 2010 0.3145
Sept. 30, 2010 0.2838
June 30, 2010 0.2838
March 31, 2010 0.2838
Jan. 4, 2010 0.2838
▸2009
1.01 USD
Sept. 30, 2009 0.2531
June 30, 2009 0.2531
March 31, 2009 0.2531
Jan. 2, 2009 0.2531
▸2008
0.87 USD
Sept. 30, 2008 0.2186
June 30, 2008 0.2186
March 31, 2008 0.2186
Jan. 2, 2008 0.2186
▸2007
0.75 USD
Sept. 28, 2007 0.1879
June 29, 2007 0.1879
March 30, 2007 0.1879
Jan. 2, 2007 0.1879
▸2006
0.66 USD
Sept. 29, 2006 0.1649
June 30, 2006 0.1649
March 31, 2006 0.1649
Jan. 3, 2006 0.1649
▸2005
0.55 USD
Sept. 30, 2005 0.1381
June 30, 2005 0.1381
March 31, 2005 0.1381
Jan. 3, 2005 0.1381
▸2004
0.46 USD
Sept. 30, 2004 0.1150
June 30, 2004 0.1150
March 31, 2004 0.1150
Jan. 2, 2004 0.1150
▸2003
0.31 USD
Sept. 30, 2003 0.0767
June 30, 2003 0.0767
March 31, 2003 0.0767
Jan. 2, 2003 0.0767
▸2002
0.30 USD
Sept. 30, 2002 0.0752
June 28, 2002 0.0752
March 29, 2002 0.0752
Jan. 2, 2002 0.0752
▸2001
0.29 USD
Sept. 28, 2001 0.0729
June 29, 2001 0.0729
March 30, 2001 0.0729
Jan. 2, 2001 0.0729
▸2000
0.29 USD
Sept. 29, 2000 0.0713
June 30, 2000 0.0713
March 31, 2000 0.0713
Jan. 7, 2000 0.0713
▸1999
0.26 USD
Sept. 30, 1999 0.0652
June 30, 1999 0.0652
March 31, 1999 0.0652
Jan. 4, 1999 0.0652
▸1998
0.22 USD
Sept. 30, 1998 0.0552
June 30, 1998 0.0556
March 31, 1998 0.0556
Jan. 2, 1998 0.0556
▸1997
0.22 USD
Sept. 30, 1997 0.0499
Sept. 4, 1997 0.0249
June 30, 1997 0.0499
March 28, 1997 0.0499
Jan. 2, 1997 0.0499
▸1996
0.18 USD
Sept. 30, 1996 0.0441
June 28, 1996 0.0441
March 29, 1996 0.0441
Jan. 2, 1996 0.0441
▸1995
0.16 USD
Sept. 29, 1995 0.0393
June 30, 1995 0.0393
March 31, 1995 0.0393
Jan. 3, 1995 0.0393
▸1994
0.14 USD
Sept. 30, 1994 0.0355
June 30, 1994 0.0355
March 31, 1994 0.0355
Jan. 3, 1994 0.0355
▸1993
0.13 USD
Sept. 30, 1993 0.0316
June 30, 1993 0.0316
March 31, 1993 0.0316
Jan. 4, 1993 0.0316
▸1992
0.12 USD
Sept. 30, 1992 0.0288
June 30, 1992 0.0288
March 31, 1992 0.0288
Jan. 2, 1992 0.0288
▸1991
0.11 USD
Sept. 30, 1991 0.0278
June 28, 1991 0.0278
March 29, 1991 0.0278
Jan. 2, 1991 0.0278
▸1990
0.10 USD
Sept. 28, 1990 0.0259
June 29, 1990 0.0259
March 30, 1990 0.0259
Jan. 2, 1990 0.0259
▸1989
0.10 USD
Sept. 29, 1989 0.0240
June 30, 1989 0.0240
March 31, 1989 0.0240
Jan. 3, 1989 0.0240
▸1988
0.08 USD
Sept. 30, 1988 0.0206
June 30, 1988 0.0206
March 31, 1988 0.0206
Jan. 4, 1988 0.0206
▸1987
0.07 USD
Sept. 30, 1987 0.0177
June 30, 1987 0.0177
March 31, 1987 0.0177
Jan. 2, 1987 0.0177
▸1986
0.05 USD
Sept. 3, 1986 0.0158
June 3, 1986 0.0158
March 10, 1986 0.0158
▸1985
0.06 USD
Dec. 10, 1985 0.0158
Sept. 3, 1985 0.0144
June 4, 1985 0.0144
March 4, 1985 0.0144
▸1984
0.06 USD
Dec. 11, 1984 0.0144
Aug. 31, 1984 0.0144
June 5, 1984 0.0138
March 5, 1984 0.0138
▸1983
0.04 USD
Dec. 5, 1983 0.0138
Sept. 2, 1983 0.0138
June 7, 1983 0.0138
▸1973
0.02 USD
Feb. 28, 1973 0.0168
Upcoming Dividends
Name Payment Date Status Amount
Becton, Dickinson and Company Sep 30, 2026 Upcoming 1.05 USD
Becton, Dickinson and Company Jun 30, 2026 1.05 USD
Becton, Dickinson and Company Mar 31, 2026 1.05 USD
Becton, Dickinson and Company Dec 31, 2025 0.825472 USD
Stock Splits
Split Date Split Ratio to 1
March 3, 1986 2:1
March 1, 1993 2:1
Aug. 16, 1996 2:1
Aug. 21, 1998 2:1
April 1, 2022 Needs review
Feb. 10, 2026 1.272
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion